Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group.
暂无分享,去创建一个
James R. Anderson | S. Donaldson | C. Paidas | D. Hawkins | W. Meyer | E. Lyden | D. Parham | P. Breitfeld | L. Mascarenhas | D. Walterhouse